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Abstract
Background: Endometriosis has been described to impair fertility through various mechanisms. However, studies
evaluating the reproductive outcomes of women undergoing assisted reproductive technologies show
controversial results. The aim of this study is to assess whether the reproductive outcome is impaired among
women with endometriosis-associated infertility undergoing IVF.
Methods: A retrospective cohort study was performed, including women undergoing IVF reported by the Red
Latinoamericana de Reproduccion Asistida (Redlara) registry, between January 2010 and December 2012. The study
group included women with endometriosis-associated infertility, and the control group women with tubal factor,
endocrine disorders or unexplained infertility. Women above 40 years, severe male factor and premature ovarian
failure were excluded. The reproductive outcomes of between both groups were compared. The primary outcome
was live birth. Secondary outcomes included clinical pregnancy, miscarriage, number of oocytes retrieved and
number of fertilized oocytes. Outcomes were assessed after the first fresh IVF cycle, and were adjusted for age and
number of embryos transferred.
Results: A total of 22.416 women were included (3.583 with endometriosis and 18.833 in the control group). Mean
age of patients in the endometriosis group and control group was 34.86 (3.47) and 34.61 (3.91) respectively, p = 0.
000. The mean number of oocytes retrieved were 8.89 (6.23) and 9.86 (7.02) respectively, p = 0.000. No significant
differences were observed between groups in terms of live birth (odds ratio (OR) 1.032, p = 0.556), clinical
pregnancy (OR 1.044, p = 0.428) and miscarriage rates (OR 1.049, p = 0.623). Women with endometriosis had
significantly lower number of oocytes retrieved (incidence risk ratio (IRR) 0.917, 95% CI 0.895–0.940), however, the
number of fertilized oocytes did not differ among the two groups when adjusting for the number of oocytes
retrieved (IRR 1.003, p = 0.794). An age-stratified analysis was performed, and no differences were observed in the
reproductive outcomes between groups for women aged under 35 and 35 to 40.
Conclusions: Reproductive outcomes among women undergoing IVF and diagnosed with endometriosis-associated
infertility do not differ significantly from women without the disease. Although women with endometriosis generate
fewer oocytes, fertilization rate is not impaired and the likelihood of achieving a live birth is also not affected.
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Background
Endometriosis affects between 0.5 and 10% of women in
reproductive age [1–3] and approximately 25–40% of
women diagnosed with infertility [1]. Endometriosis is
defined as the presence of endometrial tissue outside the
uterine cavity [4]. This ectopic tissue induces a chronic
inflammatory reaction that may lead to extensive fibrosis
and adhesion formation. Clinically, endometriosis is classi-
fied as peritoneal, ovarian, and deep-infiltrating, although
they often coexist [5].
Depending on the location of the endometriotic im-
plant and the severity of the disease, several mechanisms
have been postulated to explain the reduced fecundity
observed in women affected by this condition. To date,
the evidence suggests that endometriosis has deleterious
effects on ovarian function [6, 7], tubal function [8], and
may also affect endometrial receptivity [9]. Abnormal
folliculogenesis and oocyte maturation [6, 7], increased
radical oxidative stress [10, 11], as well as imbalances in
the levels of cytokines, interleukins and various growth
factors have been described as potential contributors to
impaired fertility [11, 12].
There is a serious controversy as to whether endomet-
riosis per se, can affect the reproductive outcomes of
women undergoing assisted reproductive technologies
(ART). Several authors have found that endometriosis
have a negative impact [13–15], while others have not
found such association [16–20].
The aim of this study is to compare, in a large cohort
of women undergoing ART, the reproductive outcome




A retrospective cohort study was performed from a
prospectively collected database by the Latin American
registry of Assisted Reproduction between January 2010
and December 2012. This database corresponds to an
individualized case-by-case registry that keeps record of
data of every case performed by 145 centers belonging
to The Latin America Network of Assisted Reproduction
(REDLARA).
In order to be certified by REDLARA, the consent
forms signed by patients must include a statement
stating that the data collected may be published in
epidemiological studies, which will keep anonymity.
When desired, patients can ask for their data to be
removed of the database. Therefore no Institutional
Review Board/Ethics Committee was sought.
In addition, STROBE (STrengthening the Reporting of
OBservational studies in Epidemiology) guidelines for
cohort studies were followed to conduct this study [21].
The STROBE statement consist of a 22-item checklist
which refers to the abstract, introduction, methodology,
results and discussion of observational studies, and pro-
vide a guideline for authors intended to make strong
contributions to improving quality of reporting of these
observational studies.
Selection of participants and data collection
Women under the age of 40 years old undergoing ART
were included in the study. The study group consisted of
women diagnosed with infertility associated with endo-
metriosis. The control group included women with tubal
factor, endocrine disorders or unexplained infertility.
The diagnosis of endometriosis was performed in the
past and reported by the institution.
Cases with women aged ≥ 40, premature ovarian fail-
ure, severe male factor, and women undergoing IVF for
preimplantation genetic diagnosis were excluded from
this study.
Baseline characteristics were recorded prospectively,
as well as data from the infertility evaluation,and out-
comes derived from the controlled ovarian stimulation
including: number of oocytes retrieved, fertilization rate,
as well as pregnancy and live birth rates.
The primary outcome was live births. Secondary out-
comes included clinical pregnancy, miscarriage, number
of retrieved oocytes, and number of fertilized oocytes.
Outcomes were assessed after the first fresh IVF cycle
and analyzed per initiated cycle. These outcomes were
defined according to the terminology recommended in
the ICMART-WHO (International Committee Monitor-
ing Assisted Reproductive Technologies, World Health
Organization) glossary [22] and the updated and revised
nomenclature for the description of early pregnancy
events [23].
The database used to enter patients information by
Redlara centers had an internal validation program
which checks for consistency and does not allow incon-
sistent data from one set to another. Furthermore, each
participating institution is certified before their data is
accepted in the registry.
Statistical analysis
Descriptive data of the study population are presented as
percentages for categorical variables, and as mean (±
standard deviation) for numeric variables. Data from
both, study and control groups, were compared using
Fisher’s exact test for categorical variables and student’s
t-test for discrete numerical variables. Outcomes were
analyzed using logistic regression models for categorical
variables and negative binominal regression models for
discrete numerical variables, adjusting for age of the
female partner and number of embryos transferred. The
analysis of the number of fertilized oocytes was addi-
tionally adjusted for the number of oocytes retrieved.
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P-values below 0.05 were considered as statistically sig-
nificant. Reproductive outcomes were expressed as odds
ratio (OR) or incidence risk ratio (IRR) when using logistic
regression models or negative binomial regression models,
respectively. An age-stratified analysis was performed of
the reproductive outcomes for women aged under 35
and 35 to 40.
We estimated that the sample size of the cohort was
sufficient to detect a 3% difference in livebirth rate
between groups, with a type I error of 0.05 and a power
of 90%.
Results
A total of 22,416 women were included in the study,
3583 women with the diagnosis of endometriosis and
18,833 women without the diagnosis of endometriosis.
In the control group 36.66% had been diagnosed with
tubal factor, 20.02% with endocrine disorders, 40.66%
with unexplained infertility and in 2.48% of cases the
diagnosis was not available. Mean age was 34.83 ±
3.47 years in the endometriosis group and 34.61 ± 3.91
in the control group (p < 0.001). This difference in
0.22 years is not considered clinically significant.
A descriptive analysis of the results obtained in the fresh
IVF/ICSI cycle is shown in Table 1. Women diagnosed with
endometriosis had fewer oocytes retrieved as compared
with the control group, 8.89 (6.23) versus 9.86 (7.02)
(p < 0.001), respectively, differences that were also ob-
served in the age-stratified analysis (Table 2). Cancellation
rate was also significantly higher in the endometriosis
group compared to the control group, 2.95% versus 3.94%
(p0.005), respectively, differences that remained statisti-
cally significant in the age-stratified analysis. However, the
fertilization rate was similar between both groups, 60.28%
versus 59.54%, respectively, p = 0.159.
Reproductive outcomes
In the multivariate analysis of the reproductive out-
comes, after adjusting for the age of the female partner
and the number of embryos transferred, there was no
significant difference in live birth between the two
groups (OR 1.032, 95% CI 0.927 – 1.151). Furthermore,
no differences were found in clinical pregnancy rate (OR
1.044, 95% CI 0.938–1.162) and miscarriage rate (OR
1.048, 95% CI 0.867–1.269).
Interestingly, although in the group of women with
endometriosis the number of oocytes retrieved was
significantly lower (IRR 0.917, 95% CI 0.895–0.940), the
number of fertilized oocytes did not differ (IRR 1.003,
0.983 – 1.023) after adjusting for the number of oocytes
retrieved.
Additionally, there was a higher cancellation rate in
the endometriosis group as compared to the control
group, 3.94% versus 2.95%, although this difference in
0.99% was not considered clinically significant.
In the age-stratified analysis, the odds ratios for these
reproductive outcomes were consistent with these previous
results. Women aged under 35 with endometriosis showed
no differences in live birth (OR 1.11, 95% CI 0.984 – 1.263),
clinical pregnancy (OR 1.127, 95% CI 0.996 – 1.276) and
miscarriage rates (OR 0.910, 95% CI 0.713 – 1.161),
compared to women in the control group, Fig. 1. In this
group, women with endometriosis also had significantly
lower number of retrieved oocytes (IRR 0.903, 95% CI
0.872 – 0.936), although fertilization rates were comparable
after adjusting for the number of oocytes retrieved (IRR
1.018, 95% CI 0.989 – 1.048).
Among women aged between 35 and 40, live birth
(OR 0.953, 95% CI 0.842 – 1.078), clinical pregnancy
(OR 0.954, 95% CI 0.844 – 1.078) and miscarriage rates
(OR 1.093, 5% CI 0.890 – 1.342) were also comparable
between the endometriosis and the control group. Be-
sides, women with endometriosis also retrieved a statisti-
cally lower number of oocytes retrieved (IRR 0.920, 95%
CI 0.888 – 0.952). However, after adjusting for this
variable, fertilization rates were comparable (IRR 0.981,
95% CI 0.955 – 1.007), Fig. 1.
Discussion
The main finding of this study show that endometriosis
does not have a significant impact in live birth rate
among infertile women undergoing IVF/ICSI.
Table 1 Descriptive data of the study population and results of the IVF cycle
Control (n = 18,833) Endometriosis (n = 3,583) P values
Age 34.61 ± 3.91 34.83 ± 3.47 <0.001
N° oocytes retrieved 9.86 ± 7.02 8.89 ± 6.23 <0.001
Cancellation rate 2.95% 3.94% 0.005
Fertilization rate 59.54% 60.28% 0.159
Number of embryos transferred per ET 2.22 ± 0.70 2.15 ± 0.65 <0.001
Clinical pregnancy rate 23.76% 24.31% 0.483
Miscarriage rate 5.88% 5.86% 0.975
Live birth rate 23.35% 23.81% 0.563
Note: Values presented as mean ± SD or %
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Previous reports on the outcome of ART for endometri-
osis-associated infertility have showed conflicting results.
Barnhart et al. [24] reported in a systematic review and
meta-analysis a significant decrease in pregnancy rates
among women with endometriosis compared with women
with tubal factor. In addition, they described that women
with endometriosis showed a significant reduction in the
number of oocytes retrieved, as well as lower fertilization
and implantation rates.
Interestingly, a more recent meta-analysis by Harb et al.
[25] described that ART results were dependent on the se-
verity of the disease. The presence of severe endometriosis
was associated with reduced implantation and clinical preg-
nancy rates, although the reduction in live birth rate did
Table 2 Descriptive data of the study population and results of the IVF cycle according to woman’s age category
Control Endometriosis P values
Age < 35 years n = 8,454 n = 1,516
Age 31.04 ± 2.73 31.50 ± 2.35 <0.001
N° oocytes retrieved 11.64 ± 7.48 10.32 ± 6.56 <0.001
Cancellation rate 2.12% 2.97% 0.0066
Fertilization rate 57.51% 60.10% 0.002
Number of embryos transferred per ET 2.16 ± 0.61 2.10 ± 0.57 <0.002
Clinical pregnancy rate 27.52% 30.14% 0.040
Miscarriage rate 6.06% 5.58% 0.463
Live birth rate 27.08% 29.48% 0.058
Age 35–40 years n = 10,379 n = 2,067
Age 37.51 ± 1.70 37.27 ± 1.65 <0.001
N° oocytes retrieved 8.39 ± 6.24 7.82 ± 5.74 <0.001
Cancellation rate 3.63% 4.64% 0.004
Fertilization rate 61.24% 60.41% 0.204
Number of embryos transferred per ET 2.27 ± 0.76 2.18 ± 0.70 <0.001
Clinical pregnancy rate 20.70% 20.02% 0.490
Miscarriage rate 5.73% 6.07% 0.555
Live birth rate 20.32% 19.64% 0.500
Note: Values presented as mean ± SD or %
Fig. 1 Reproductive outcomes of women with endometriosis compared to the control group, age-stratified analysis
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not reach statistical significance. Meanwhile, women with
mild endometriosis showed comparable results in terms of
implantation, clinical pregnancy and live birth rates [25]. In
contrast, the review by Barbosa et al. [26] did not report
significant differences in live birth and clinical pregnancy
rates among women with endometriosis as compared with
other causes of infertility. Furthermore, reproductive out-
comes were not affected by the severity of endometriosis.
When evaluating the effect of ovarian endometriosis
on the response to controlled ovarian stimulation (COS)
for ART, the available literature show inconsistent results
[16–18, 27, 28]. Ballester et al. [27] reported comparable
ART results when comparing women with isolated endo-
metriomas and women with coexisting ovarian and deep-
infiltrating endometriosis. Meanwhile, a recent study by
Ashrafi et al. [17] observed in a prospective cohort a sig-
nificantly poorer ovarian response to stimulation and
lower number of metaphase-II oocytes retrieved among
women with endometriomas as compared with a control
group. Nevertheless, the quality of the embryos obtained
and clinical pregnancy rates were comparable.
In term of implantation, various studies have reported an
impairment in endometrial decidualization and receptivity,
including a local dysregulation in the progesterone re-
sponse, an alteration in the expression of integrins and
interleukins among others [29–31]. However, studies ex-
amining embryo implantation, show contradicting results
[32–34]. In a retrospective analysis of ART outcomes and
oocyte donation programs, Simón et al. [33], reported a
significantly reduced pregnancy and implantation rates
when oocytes came from donors with endometriosis,
although implantation rates among women with and with-
out endometriosis were comparable when oocytes came
from donors without endometriosis. These results suggest
that infertility in patients with endometriosis seem to be
more dependent on the quality of the oocyte rather than an
impaired decidualization.
Overall, we hypothesize that the discrepancies among
different studies are explained by the disparity_when
controlling for confounding factors due to the nature of
the different study design, as well as the high heterogen-
eity of the inclusion criteria and the low number of
patients enrolled.
When comparing published literature with the re-
sults obtained in our study, even though women with
endometriosis-associated infertility yielded significantly
lower number of oocytes, fertilization rates were com-
parable with that of the control group (Fig. 1). Besides,
after adjusting for the number of embryos transferred and
the age of the female partner, clinical pregnancy, miscar-
riage and live birth rates did not differ in the two groups.
In a further attempt to assess whether this lack of differ-
ence was affected by age, the odds ratios obtained in the
age-stratified analysis did not vary when comparing
women with endometriosis and the control group neither
under the age of 35 nor between the ages of 35 and 40
(Fig. 1), suggesting that these outcomes were not influ-
enced significantly by the loss of ovarian reserve.
There are several factors that are consistent with our ana-
lysis. Most significantly, the large number of patients in-
cluded in the study, the largest cohort published so far [26],
which provided a considerable gain in statistical power. Be-
sides, the prospective nature of the database in addition to
its individualized case-by-case registry empower the results
obtained in the analysis. Furthermore, data from this study
is obtained from a multinational database, and compared to
a national database, it encompasses a wider variety of eth-
nics, enhancing the external validity of our analysis.
However, this study has several limitations that need to
be addressed. First, it was not possible to differentiate mild
from moderate or severe endometriosis in the analysis,
since these data were not available in the registry. In
addition, no distinction was made between women who
had undergone ovarian surgery to remove endometriotic
lesions prior to ART from those who had not, impeding
the identification of patients with a potentially reduced
ovarian response to hyperstimulation. Furthermore, it was
not possible to identify women who were disease-free at
the time of IVF from those with active disease. Hence, a
stratified analysis of patients with poorer prognosis, par-
ticularly in terms of live birth, was not possible.
Conclusions
We conclude, that in spite of its limitations, the data
examined in this study is a reflection that the rate of live
birth after ART, is not affected by the presence or past
history of endometriosis.
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